Urinary Tract Infection Management

Treatment Duration and Antimicrobial Regimens

• For patients with prompt symptom resolution, the Infectious Diseases Society of America recommends a treatment duration of 7 days 1
• For patients with delayed response, the Infectious Diseases Society of America recommends a treatment duration of 10-14 days 1
• A 3-day antimicrobial regimen may be considered for women aged ≤65 years, but a longer course is warranted for older women, according to the Infectious Diseases Society of America 1
• The shortest effective course of antibiotics is generally 5-7 days to reduce the risk of resistance, as recommended by the American Urological Association and the European Urology guidelines 2, 3

Diagnostic Considerations

• The Infectious Diseases Society of America recommends obtaining a urine culture before initiating antibiotics to guide therapy 1
• Repeat urine culture should be performed before prescribing additional antibiotics, and culture-directed antibiotics should be used for no longer than 7 days, as recommended by the American Urological Association 4

Catheter Management

• The Infectious Diseases Society of America recommends replacing indwelling catheters if present for >2 weeks at onset of UTI 1

Prevention of Recurrent UTIs

• Increased water intake of an additional 1.5L of water daily is recommended to prevent UTIs, as suggested by the JAMA network open guidelines 5
• Cranberry products containing proanthocyanidin levels of 36 mg are recommended to prevent UTIs, according to the JAMA network open guidelines 5
• Vaginal estrogen is recommended for postmenopausal women to prevent UTIs, as suggested by the JAMA network open guidelines and the European Association of Urology 5, 3
• Non-antimicrobial measures, such as urge-initiated and post-coital voiding, avoidance of spermicide-containing contraceptives, may help prevent recurrence, as recommended by the American College of Radiology 6

Risk Factors and Assessment

• The American College of Radiology recommends assessing risk factors, including medical conditions (e.g., diabetes, immunosuppression), anatomical factors (e.g., history of urinary tract surgery/trauma), and functional issues (e.g., urinary incontinence, high post-void residuals) 6
• Recurrent UTIs are defined as ≥3 episodes in 12 months or ≥2 episodes in 6 months, with documentation of the patient's infection pattern, including timing of previous infections, relationship to sexual activity, and previous culture results and antibiotic responses, as recommended by the American College of Radiology 6

Imaging and Laboratory Tests

• Imaging is generally low yield in uncomplicated recurrent UTIs, but may be considered if there is rapid recurrence, bacterial persistence despite therapy, recurrent pyelonephritis, gross hematuria after infection resolution, or symptoms of pneumaturia or fecaluria, as recommended by the American College of Radiology 6
• Urine studies should include urinalysis and culture with susceptibility testing to document organism(s) and resistance patterns, as recommended by the American College of Radiology 6

Treatment Options

• Nitrofurantoin is recommended as a first-line agent for uncomplicated UTIs due to its high efficacy and low resistance rates globally, according to the World Health Organization and the European guidelines 7
• Trimethoprim-sulfamethoxazole (TMP-SMX) is also recommended as first-line therapy, but its use may be limited by potential interactions with certain medications, such as levodopa, as noted by the World Health Organization and the European guidelines 7
• Fosfomycin is a single-dose therapy option with no significant drug interactions, but has lower clinical and microbiologic resolution compared to nitrofurantoin, as noted by the WHO guidelines 7
• Fluoroquinolones, such as ciprofloxacin and levofloxacin, are associated with serious side effects and should be reserved for more serious infections, according to FDA warnings 7
• Parenteral therapy with ceftriaxone or cefotaxime is recommended for suspected pyelonephritis, as these agents have no significant interactions with patient's medications, as recommended by the European Urology guidelines 3
• The European Urology guidelines recommend the following oral treatment options for complicated UTIs:

Prophylactic Options

4

Special Populations

• All pregnant women should be screened for bacteriuria by urine culture at least once in early pregnancy to identify asymptomatic bacteriuria, as recommended by the American Urological Association 8
• First-line treatment options for pregnant women include nitrofurantoin, fosfomycin trometamol, pivmecillinam, and trimethoprim-sulfamethoxazole, as recommended by the European Urology guidelines 8, 3, 5
• Recurrent UTIs in pregnant women are defined as more than 2 culture-positive UTIs in 6 months or more than 3 in one year, and nitrofurantoin is recommended as a first-line treatment due to low resistance rates, as per the American Urological Association 4

Follow-up and Self-Management

• Post-treatment follow-up is not necessary for asymptomatic patients after treatment completion, but urine culture 1-2 weeks after completing treatment can confirm cure, as recommended by the Infectious Diseases Society of America and the European Urology guidelines 3, 2
• Self-start antibiotic therapy can be considered for reliable patients who can obtain urine specimens before starting therapy, as recommended by the American Urological Association 4